+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Suprane"

Inhalation Anaesthesia Market Report and Forecast 2025-2034 - Product Thumbnail Image

Inhalation Anaesthesia Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Suprane (desflurane) is an anesthetic drug used in the induction and maintenance of general anesthesia. It is a volatile liquid that is administered through inhalation. It is a fluorinated hydrocarbon that is rapidly metabolized in the body, making it a short-acting anesthetic. Suprane is known for its rapid onset and offset of action, making it a popular choice for short surgical procedures. It is also used in combination with other anesthetics to provide a balanced anesthetic effect. Suprane is used in a variety of medical settings, including operating rooms, intensive care units, and emergency departments. It is also used in veterinary medicine. The drug is available in a variety of formulations, including a premixed solution and a vaporizer. The Suprane market is highly competitive, with several major players. These include Baxter International, Hospira, and AbbVie. Other companies in the market include Merck, Teva Pharmaceuticals, and Mylan. Show Less Read more